Novogene Co Ltd - ESG Rating & Company Profile powered by AI
The dashboard contains a Q&A table for Novogene Co Ltd. Browse to the end of the page for potential risks for Novogene Co Ltd based on industry, location and marketcap. The ESG rating includes 17 United Nations SDGs including: 'Zero Hunger', 'Responsible Production & Consumption' and 'Life below Water'.
Novogene Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.7; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 314 | Trulieve Cannabis Corp | 6.8 | High |
| 314 | Vicore Pharma Holding AB | 6.8 | High |
| 337 | Novogene Co Ltd | 6.7 | High |
| 337 | Calyxt Inc | 6.7 | High |
| 337 | CanSino Biologics Inc | 6.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Novogene Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Novogene Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Novogene Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Novogene Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Novogene Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Novogene Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Novogene Co Ltd offer flexible work?
Sign up for free to unlockDoes Novogene Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Novogene Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Novogene Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Novogene Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Novogene Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Novogene Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Novogene Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Novogene Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Novogene Co Ltd disclose water use targets?
Sign up for free to unlockDoes Novogene Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Novogene Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Novogene Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Novogene Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Novogene Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Novogene Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Novogene Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Novogene Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Novogene Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Novogene Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Novogene Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Novogene Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Novogene Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Novogene Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Novogene Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Novogene Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Novogene Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Novogene Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Novogene Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Novogene Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Novogene Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Novogene Co., Ltd. provides genomic services and solutions worldwide. The company offers genomic solutions, such as human genome sequencing, gene regulation, single cell sequencing, animal and plant solutions, and microbial genome sequencing; and cancer genomic profiling, whole exome sequencing, and FFPE RNA sequencing, as well as clinical-grade whole exome sequencing services. It also provides NovoFocus, a next-generation sequencing based companion diagnostic assay for PARP inhibitor therapies; and NovoNeoantigen, a bioinformatics pipeline for the identification of cancer neoantigens with whole exome sequencing and whole transcriptome sequencing data from paired tumor-normal samples. Novogene Co., Ltd. has a strategic partnership with Hummingbird Bioscience Pte. Ltd. to support the development of investigational drug candidate HMBD-001, an anti-HER3 antibody to be evaluated for treatment of various tumor types, including NRG1-fusion driven cancers. The company was founded in 2011 and is headquartered in Beijing, China.